Importance of immunostimulation for community acquired pneumonia management Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Year: 2014
LSC Abstract – Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met (winner of the LSC 2015 Young Investigator William MacNee Award) Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Presentation from Italian Fellowship recipient Diffuse lung disease in children"""resentation from Italian Fellowsh" Source: International Congress 2017 – ERS Italian Day programme Year: 2017
In the spotlight: first ERS Early Career Member Award winner, the ERS Lung Science Conference 2020 and new ECMC members Source: Breathe, 15 (4) 330; 10.1183/20734735.0253-2019 Year: 2019
Impact on Adherence to the 2012 Evaluation and Management of Pediatric Community Acquired Pneumonia Philippine Academy of Pediatric Pulmonologist (PAPP) Update Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
The results of immunotherapy of community acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Early Career Members at the ERS Lung Science Conference 2020: metabolic alterations in lung ageing and disease Source: Breathe, 16 (3) 200063; 10.1183/20734735.0063-2020 Year: 2020
Imaging of empyema (EMP) in children: How bedside ultrasonography (US) impact on clinical practice? Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014
What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease? Source: Research Seminar 2007 - Severe Asthma Year: 2007
GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease Source: Breathe 2014; 10:173-175 Year: 2014
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017 Year: 2018
ERS International Congress 2019: highlights from Best Abstract awardees Source: Breathe, 15 (4) e143; 10.1183/20734735.0330-2019 Year: 2019
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019
LATE-BREAKING ABSTRACT: Why asthma still kills National Review of Asthma Deaths (NRAD) Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014
GPs Meet Rare Lung Disorders Task Force factsheet: lung disease in children with immunodeficiencies Source: Breathe 2014; 10: 271-272 Year: 2014
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research Source: Eur Respir J, 52 (5) 1801671; 10.1183/13993003.01671-2018 Year: 2018
Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019
In the spotlight: Early Career Member Awardee 2020, ERS Lung Science Conference 2021, and Sleep and Breathing 2021 Source: Breathe, 16 (4) 200199; 10.1183/20734735.0199-2020 Year: 2020